Download PDF
Thromb Haemost 1977; 38(04): 0863-0873
DOI: 10.1055/s-0038-1651904
Original Article
Schattauer GmbH

Reduction of Coagulation Factor XIII Concentration in Patients with Myocardial Infarction, Cerebral infarction, and other Thromboembolic Disorders

Norma Alkjaersig
1   Washington University School of Medicine, Box 8073, 660 South Euclid Avenue, Department of Medicine, St. Louis, Missouri 63110, U.S.A.
,
Anthony P. Fletcher
1   Washington University School of Medicine, Box 8073, 660 South Euclid Avenue, Department of Medicine, St. Louis, Missouri 63110, U.S.A.
,
Martin Lewis
1   Washington University School of Medicine, Box 8073, 660 South Euclid Avenue, Department of Medicine, St. Louis, Missouri 63110, U.S.A.
,
Roy Ittyerah
1   Washington University School of Medicine, Box 8073, 660 South Euclid Avenue, Department of Medicine, St. Louis, Missouri 63110, U.S.A.
› Author Affiliations
Further Information

Publication History

Publication Date:
04 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

Coagulation factor XIII and plasma fibrinogen chromatographic assays have been performed serially in patients suffering from acute myocardial and cerebral infarction, and in others with disseminated intravascular coagulation. The findings were compared with 2 groups of “controls”; normal clinically-well subjects and hospitalized patients with cerebral infarction who exhibited minimal, stable, or improving neurological deficits. Substantial depression of factor XIII concentrations developed in the 3 patient groups, together with concomitant significant increases in the proportion and concentration of plasma high molecular weight fibrin(ogen) complexes (HMWFC). An inverse correlation (p<0.05) between coagulation factor XIII concentration and percentage of HMWFC was demonstrated in the early stages of the illness. These findings suggest that depression of coagulation factor XIII concentration in these states, is secondary to extra vascular or intravascular coagulation and may reflect its degree.

 

  • References

  • 1 Alkjaersig N, Roy L, Fletcher A, Murphy E. 1973; Analysis of gel exclusion chromatographic data by chromatographic plate theory analysis: Application to plasma fibrinogen chromatography. Thrombosis Research 3: 525.
    CrossrefPubMedSearch in Google Scholar
  • 2 Alkjaersig N, Fletcher A, Burnstein R. 1975; Association between oral contraceptive use and thromboembolism: A new approach to its investigation based on plasma fibrinogen chromatography. American Journal of Obstetrics and Gynaecology 122: 199.
    CrossrefPubMedSearch in Google Scholar
  • 3 Alkjaersig N, Fletcher A, Lewis M, Cole B, Ingelfinger J, Robson A. 1976; Pathophysiological response of blood coagulation system in acute glomerulonephritis. Kidney International 10: 319.
    CrossrefPubMedSearch in Google Scholar
  • 4 Armitage P. 1971. Statistical methods in medical research. John Wiley and Sons; New York.:
    Search in Google Scholar
  • 5 Cooper H, Bowie E, Didisheim P, Owen Jr. C. 1971; Paradoxic changes in platelets and fibrinogen in chronically-induced intravascular coagulation. Mayo Clinic Proceedings 46: 521.
    PubMedSearch in Google Scholar
  • 6 Coopland A, Alkjaersig N, Fletcher A. 1969; Reduction in plasma factor XIII (fibrin stabilizing factor) concentration during pregnancy. Journal of Laboratory and Clinical Medicine 73: 144.
    PubMedSearch in Google Scholar
  • 7 Cooperative Clinical Trial.. 1973; Anticoagulants in acute myocardial infarction. Journal of the American Medical Association 225: 724.
    CrossrefPubMedSearch in Google Scholar
  • 8 Duckert F, Jung E, Schmerling D. 1960; A hitherto undescribed congenital hemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombosis et Diathesis Haemorrhagica 5: 179.
    PubMedSearch in Google Scholar
  • 9 Fletcher A, Alkjaersig N, O’Brien J, Tulevski V. 1970; Blood hypercoagulability and thrombosis. Transactions of the Association of American Physicians 83: 159.
    PubMedSearch in Google Scholar
  • 10 Fletcher A, Alkjaersig N, Roy L, Owens O. 1972. a Early detection of blood hypercoagulable states and early thromboembolic lesions in man. In: Erdrich M. (ed.) Advances in automated analysis. 1972. Technicon International Congress. Mediaid, Incorporated; Tarrytown: vol. 4 31.
    Search in Google Scholar
  • 11 Fletcher A, Alkjaersig N. 1972; b Blood hypercoagulability, intravascular coagulation and thrombosis: New diagnostic concepts. Thrombosis et Diathesis Haemorrhagica Suppl. 45: 389.
    PubMedSearch in Google Scholar
  • 12 Fletcher A, Alkjaersig N, Ghani M, Tulevski V. 1973; a Response of blood coagulation and plasma fibrinolytic enzyme systems in acute myocardial infarction. Clinical Research 21: 862.
    PubMedSearch in Google Scholar
  • 13 Fletcher A, Alkjaersig N, Davies A, Lewis M, Brooks J, Hardin W, Landau W, Raichle M. 1976; Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke. Stroke 7: 337.
    CrossrefPubMedSearch in Google Scholar
  • 14 Fletcher A, Alkjaersig N, O’Brien J, Tulevski V. 1977; a Fibrinogen catabolism in the surgically-treated patients and in those with post-operative venous thrombosis. Correlation of plasma fibrinogen chromatographic findings with 125I-labelled fibrinogen scan findings. Journal of Laboratory and Clinical Medicine 89: 1349.
    PubMedSearch in Google Scholar
  • 15 Fletcher A, Alkjaersig N. 1977 b The use and monitoring of antithrombotic drug therapy: The need for a new approach. Thrombosis and Haemostasis. in press.
    PubMedSearch in Google Scholar
  • 16 Fletcher A, Alkjaersig N. 1977. c Physiological and pathophysiological study of blood coagulation system function by plasma fibrinogen chromatography. In: Ritchie R. (ed.) Automated Immunoanalysis. Marcel Dekker; New York: in press.
    Search in Google Scholar
  • 17 Ittyerah R, Alkjaersig N, Fletcher A, Chaplin Jr. H. 1976; Coagulation factor XIII concentration in sickle cell disease. Journal of Laboratory and Clinical Medicine 88: 546.
    PubMedSearch in Google Scholar
  • 18 Laki K. (ed.) 1972; The biological role of the clot stabilizing enzymes: Transglutaminase and factor XIII. Annals of the New York Academy of Science 202: 348.
    PubMedSearch in Google Scholar
  • 19 Lewis J. 1972; Hemorrhagic disease associated with inhibitors of fibrin crosslinkage. In: The biological role of clot stabilizing enzymes: Transglutaminase and factor XIII. Annals of the New York Academy of Science 202: 213.
    CrossrefPubMedSearch in Google Scholar
  • 20 Lorand L, Dickenman R. 1955; Assay method for the “fibrin stabilizing factor”. Proceedings of the Society of Experimental Biology and Medicine 89: 45.
    PubMedSearch in Google Scholar
  • 21 Lorand L, Jacobsen A, Bruner-Lorand J. 1968; A pathological inhibitor of fibrin cross-linking. Journal of Clinical Investigation 47: 268.
    CrossrefPubMedSearch in Google Scholar
  • 22 Lorand L, Urayama T, DeKiewiet J, Nossel H. 1969; Diagnostic and genetic studies in fibrin stabilizing factor with a new assay based on amine incorporation. Journal of Clinical Investigation 48: 1054.
    CrossrefPubMedSearch in Google Scholar
  • 23 Mancini G, Carbonara A, Heremans J. 1965; Immunochemical quantitation of antigens by single radial immunodiffusion. International Journal of Immunochemistry 2: 253.
    PubMedSearch in Google Scholar
  • 24 McKay D. 1968; Pathology, diagnosis and therapy of disseminated intravascular coagulation. Proceedings of the Royal Society of Medicine 61: 1129.
    PubMedSearch in Google Scholar
  • 25 Medical Research Council. 1969; Assessment of short-term anticoagulant administration after cardiac infarction. British Medical Journal 1: 335.
    CrossrefPubMedSearch in Google Scholar
  • 26 Merskey C, Johnson A, Kleiner G, Wohl H. 1967; The defibrination syndrome clinical features and laboratory diagnosis. British Journal of Hematology 13: 528.
    CrossrefPubMedSearch in Google Scholar
  • 27 Miloszewski K, Losowski M. 1970; The half-life of factor XIII in vivo. British Journal of Hematology 19: 685.
    CrossrefPubMedSearch in Google Scholar
  • 28 Nicolaides A, Kakkar V, Renney J, Kidner P, Hutchison D, Clarke M. 1971; Myocardial infarction and deep vein thrombosis. British Medical Journal 1: 432.
    CrossrefPubMedSearch in Google Scholar
  • 29 Nussbaum M, Morse B. 1964; Plasma fibrin stabilizing factor activity in various diseases. Blood 23: 669.
    PubMedSearch in Google Scholar
  • 30 Owen Jr. C, Bowie E, Cooper H. 1973; Turnover of fibrinogen and platelets in dogs undergoing induced intravascular coagulation. Thrombosis Research 2: 251.
    CrossrefPubMedSearch in Google Scholar
  • 31 Rapaport S, Hjort P, Patch M, Jeremic M. 1966; Consumption of serum factors and prothrombin during intravascular clotting in rabbits. Scandinavian Journal of Hematology 3: 59.
    PubMedSearch in Google Scholar
  • 32 Ratnoff O, Menzie C. 1951; A new method for the determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine 37: 316.
    PubMedSearch in Google Scholar
  • 33 Warlow C, Ogston O, Douglas A. 1972; Venous thrombosis following strokes. Lancet I: 1305.
    PubMedSearch in Google Scholar
  • 34 Welch D, Coleman R, Hardin W, Siegel B. 1975; Brain scanning in cerebrovascular disease. A reappraisal. Stroke 6: 136.
    CrossrefPubMedSearch in Google Scholar